Grant: Project Grant - Priority Announcement: Aging
Université Laval
$100,000.00
Roles of SPARC against muscle atrophy, sarcopenia and age-related metabolic disorders.
FY 2022-23
Summary
Sarcopenia represents a loss of muscle associated to aging. Exercise reverses sarcopenia and improves age-related diseases. We have shown that the exercise-induced gene SPARC modulates muscle differentiation, and Sparc overexpression mimics exercise effects, whereas Sparc deficiency (KO) leads to an aging phenotype (muscle atrophy) which is improved by exercise. Therefore, we hypothesize that SPARC, similarly to exercise, protects against muscle atrophy, sarcopenia and age-related metabolic disorders.
The first objective is to compare the effects of Sparc overexpression (Tg) and exercise on sarcopenia and age-related metabolic disorders in sedentary and exercised Sparc Tg and wild-type (WT) mice sacrificed at 6 months (young adult) and 18 months (old) of age. Body composition, glucose tolerance, lipid profiles, muscle mass and power, as well as markers for skeletal muscle integrity and metabolism will be analyzed in 96 mice.
The second objective is to investigate SPARC implications in muscle atrophy and its recovery. One hindlimb of each Sparc KO, Sparc Tg and WT mouse will be immobilized for 2 weeks and remobilized for 2 weeks. Muscle mass and markers for protein degradation, regeneration and inflammation in muscle will be analyzed in 126 mice (6 months old).
The third objective is to compare the effects of pre-exercise training and SPARC injection on muscle atrophy and its recovery. SPARC will be injected during both immobilization and remobilization periods. Muscle mass and selected markers for muscle metabolism will be analyzed in 96 mice (18 months old).
The proposed study will characterize SPARC roles against muscle atrophy, sarcopenia and age-related health disorders. A long-term possibility is the development of an "exercise pill" that will optimize or act similarly to exercise for elderly peoples and individuals with limited physical ability or activity including bedridden and hospitalized patients.
Department
Program
Project Grant - Priority Announcement: Aging
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
472283
Name
St-Amand Jonny
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Biological and Clinical Aspects of Aging
Projecttitle
Roles of SPARC against muscle atrophy, sarcopenia and age-related metabolic disorders.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Aging
Keyworddelim
Age-Related Diseases; Disease Prevention; Metabolic Diseases; Molecular Mechanisms; Muscle Atrophy; Physical Exercise; Sparc; Transgenic Mice
Abstract
Sarcopenia represents a loss of muscle associated to aging. Exercise reverses sarcopenia and improves age-related diseases. We have shown that the exercise-induced gene SPARC modulates muscle differentiation, and Sparc overexpression mimics exercise effects, whereas Sparc deficiency (KO) leads to an aging phenotype (muscle atrophy) which is improved by exercise. Therefore, we hypothesize that SPARC, similarly to exercise, protects against muscle atrophy, sarcopenia and age-related metabolic disorders.
The first objective is to compare the effects of Sparc overexpression (Tg) and exercise on sarcopenia and age-related metabolic disorders in sedentary and exercised Sparc Tg and wild-type (WT) mice sacrificed at 6 months (young adult) and 18 months (old) of age. Body composition, glucose tolerance, lipid profiles, muscle mass and power, as well as markers for skeletal muscle integrity and metabolism will be analyzed in 96 mice.
The second objective is to investigate SPARC implications in muscle atrophy and its recovery. One hindlimb of each Sparc KO, Sparc Tg and WT mouse will be immobilized for 2 weeks and remobilized for 2 weeks. Muscle mass and markers for protein degradation, regeneration and inflammation in muscle will be analyzed in 126 mice (6 months old).
The third objective is to compare the effects of pre-exercise training and SPARC injection on muscle atrophy and its recovery. SPARC will be injected during both immobilization and remobilization periods. Muscle mass and selected markers for muscle metabolism will be analyzed in 96 mice (18 months old).
The proposed study will characterize SPARC roles against muscle atrophy, sarcopenia and age-related health disorders. A long-term possibility is the development of an "exercise pill" that will optimize or act similarly to exercise for elderly peoples and individuals with limited physical ability or activity including bedridden and hospitalized patients.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
St-Amand, Jonny
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~